Disclosures for "Care of Dystrophinopathy Carriers: Survey Results of Provider Practices in the United States"
-
The institution of Dr. Scavina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Scavina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Parent Project Muscular Dystrophy.
-
Mrs. Banks has received personal compensation for serving as an employee of Parent Project Muscular Dystrophy. Mrs. Banks has received personal compensation in the range of $0-$499 for serving as a one-time speaker with Texas Society of Genetic Counselors.
-
Dr. Cappa has received personal compensation in the range of $0-$499 for serving as an Expert Witness for iMPRove.
-
Dr. Chambers has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Birth Defects Research - The Publisher Wiley. The institution of Dr. Chambers has received research support from Amgen. The institution of Dr. Chambers has received research support from AstraZeneca. The institution of Dr. Chambers has received research support from GlaxoSmithKline. The institution of Dr. Chambers has received research support from Janssen Pharmaceuticals. The institution of Dr. Chambers has received research support from Pfizer, Inc. The institution of Dr. Chambers has received research support from Regeneron. The institution of Dr. Chambers has received research support from Hoffman La-Roche-Genentech. The institution of Dr. Chambers has received research support from Genzyme Sanofi-Aventis. The institution of Dr. Chambers has received research support from Takeda Pharmaceutical Company Limited. The institution of Dr. Chambers has received research support from Sanofi. The institution of Dr. Chambers has received research support from UCB Pharma, USA. The institution of Dr. Chambers has received research support from Leo Pharma. The institution of Dr. Chambers has received research support from Sun Pharma Global FZE. The institution of Dr. Chambers has received research support from Gilead. The institution of Dr. Chambers has received research support from Novartis. The institution of Dr. Chambers has received research support from the Gerber Foundation. The institution of Dr. Chambers has received research support from NIH.